Predicting clinical response in psoriatic arthritis through integrative analysis of transcriptomics and proteomics
Background The therapeutic response to disease-modifying antirheumatic drugs (DMARDs) remains relatively low in psoriatic arthritis (PsA), leading to delayed disease control and frequent treatment switches. Predictive biomarkers may enable personalized treatment and earlier dise…